$17M Off-Label Marketing Whistleblower Reward

A whistleblower in an off-label marketing case against Boehringer Ingelheim Pharmaceuticals Inc. will receive more than $17 million as a reward.  The reward is his share of a $95 million settlement with the government.  Whistleblowers get a share of such settlements as a reward for reporting fraud under the False Claims Act. Robert Heiden, a former sales representative for Boehringer, blew the whistle on the company’s illegal off-label marketing of three different drugs.  The three drugs were Aggrenox, Combivent, and Micardis. The government alleged that Boehreinger marketed these...

read more

Medicare fraud whistleblowers to share in $5.25M

Medicare fraud whistleblowers will get a share of the $5.25 million settlement reached between the United States Department of Justice and a major pharmacy chain.  RxAmerica, a subsidiary of CVS Caremark, settled claims that it misrepresented the cost of prescription drugs to seniors under Medicare part D. Under the False Claims Act, a whistleblower receives a percentage of any monies recovered by the government.  The amount a whistleblower could receive ranges from 15 to 30 percent of the total monetary recovery by the government. If you have non-public information about Medicare fraud or...

read more